AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
22.56
+1.66 (7.94%)
At close: May 29, 2025, 4:00 PM
22.55
-0.01 (-0.04%)
After-hours: May 29, 2025, 6:30 PM EDT
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $662.82 million as of May 29, 2025. Its market cap has increased by 3.65% in one year.
Market Cap
662.82M
Enterprise Value
668.84M
1-Year Change
3.65%
Ranking
Category
Stock Price
$22.56
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $662.82M, an increase of 114.71%. That is a compound annual growth rate of 9.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2025 | 614.10M | 52.42% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.65B |
| Johnson & Johnson | 368.92B |
| AbbVie | 327.99B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 271.40B |
| Abbott Laboratories | 232.18B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |